Selegiline Hydrochloride Capsule
Product Images NDC 71205-888

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Selegiline Hydrochloride (NDC 71205-888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-888-30 (500ct)

This is a prescription drug labeled Selegiline HCI 5mg packaged by Proficient Rx LP. It comes in a bottle of 30 hard gelatin capsules with an opaque white body and blue opaque cap with the imprint "P 659" in black ink on both cap and body. Each capsule contains Selegiline Hydrochloride, USP 5 mg. It is distributed by Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 and made in the USA with an ID of Q5088830. It is important to store this medicine at 20°-25°C (68°-77°F) and out of the reach of children.*

FDA Label Image

Chemical Structure (Chemstructure)

FDA Label Image

Adverse Reactions Table (Table Adverse Events V2)

This is a report of the incidence of adverse experiences encountered during placebo-controlled clinical trials of selegiline hydrochloride conducted on a sample of 50 patients. The adverse events reported include nausea, dizziness, lightheadedness, fainting, abdominal pain, confusion, hallucinations, dry mouth, dyskinesias, headache, vivid dreams, anxiety/tension, anemia, diarrhea, hair loss, insomnia, leg pain, low back pain, malaise, palpitations, urinary retention, lethargy, and weight loss.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.